Phase Ⅱ randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer .Randomized phase Ⅱ trial of everolimus in combination with tamoxifen in patients with hormone ......